Overall invitations, attendance, and referral to histology by study arm (PP analysis).</p
Humoral and cellular responses by study arm in the per-protocol cohort at the different time points....
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Description of study population and joint or muscle studied for each selected article.</p
Overall invitations, attendance, and referral to histology by study arm (ITS analysis).</p
Histopathology outcomes and overall detection rates by analysis and study arm.</p
Contingency tables of the histopathological score analysis (Hierholzer score).</p
Presents the procedure followed for identifying and selecting studies included in the review.</p
<p>Histopathological variables for the breast cancer cases included in the study.</p
<p>Microbiological results by study arm for both the ITT and per protocol analyses.</p
<p>Clinical and demographic characteristics of participants by study arm for both the ITT and per pr...
Proportions for histological diagnosis and polymerase chain reaction results.</p
Study identifiers, effect sizes (HR), 95% CI, and grouping variables for the analysis.</p
<p>Morbidity and mortality and adverse event incidence rates by study arm—intention-to-treat analysi...
<p>Histological assessment of antral and corpus (body) biopsies from all subjects.</p
Characteristics of the included studies for prognostic or clinicopathological analyses.</p
Humoral and cellular responses by study arm in the per-protocol cohort at the different time points....
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Description of study population and joint or muscle studied for each selected article.</p
Overall invitations, attendance, and referral to histology by study arm (ITS analysis).</p
Histopathology outcomes and overall detection rates by analysis and study arm.</p
Contingency tables of the histopathological score analysis (Hierholzer score).</p
Presents the procedure followed for identifying and selecting studies included in the review.</p
<p>Histopathological variables for the breast cancer cases included in the study.</p
<p>Microbiological results by study arm for both the ITT and per protocol analyses.</p
<p>Clinical and demographic characteristics of participants by study arm for both the ITT and per pr...
Proportions for histological diagnosis and polymerase chain reaction results.</p
Study identifiers, effect sizes (HR), 95% CI, and grouping variables for the analysis.</p
<p>Morbidity and mortality and adverse event incidence rates by study arm—intention-to-treat analysi...
<p>Histological assessment of antral and corpus (body) biopsies from all subjects.</p
Characteristics of the included studies for prognostic or clinicopathological analyses.</p
Humoral and cellular responses by study arm in the per-protocol cohort at the different time points....
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Description of study population and joint or muscle studied for each selected article.</p
DOI
Add to ORKG